Dashboard
Manage Tickers

CNTB


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

this-immuneering-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-friday
This Immuneering Analyst Begins Coverage O...
10/31/2025 11:29:02

btig-initiates-coverage-on-connect-biopharma-hldgs-with-buy-rating-announces-price-target-of-10
BTIG Initiates Coverage On Connect Biophar...
10/31/2025 10:16:27

BTIG analyst Julian Harrison initiates coverage on Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy rating and announces Pri...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/02/2025 17:06:31

connect-biopharma-presents-data-supporting-rademikibart-next-gen-anti-interleukin-4-receptor-alpha-antibody-at-ers-congress-2025
Connect Biopharma Presents Data Supporting...
09/29/2025 13:29:09

– Rademikibart demonstrated rapid and significant improvement in lung function and asthma control in patients, with greatest im...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/03/2025 12:08:15

connect-biopharma-completes-termination-of-adr-program-ordinary-shares-now-directly-listed-on-nasdaq
Connect Biopharma Completes Termination Of...
09/03/2025 12:06:26

hc-wainwright--co-reiterates-buy-on-connect-biopharma-hldgs-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Conn...
08/13/2025 17:33:51

HC Wainwright & Co. analyst Brandon Folkes reiterates Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and maintains $7 ...

connect-biopharma-hldgs-q2-eps-023-misses-022-estimate-sales-48000k-down-from-24116m-yoy
Connect Biopharma Hldgs Q2 EPS $(0.23) Mis...
08/13/2025 13:14:32

Connect Biopharma Hldgs (NASDAQ:CNTB) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimat...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/22/2025 12:07:15

connect-biopharma-to-terminate-adr-program-and-list-ordinary-shares-directly-on-nasdaq
Connect Biopharma To Terminate ADR Program...
07/21/2025 13:06:41

Connect Biopharma Holdings Limited (NASDAQ:CNTB) ("Connect Biopharma" or the "Company"), a clinical-stage bioph...

connect-biopharma-regains-nasdaq-compliance-for-minimum-bid-price-requirement
Connect Biopharma Regains Nasdaq Complianc...
07/17/2025 13:15:03

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
07/11/2025 17:06:03

connect-biopharma-holdings-announces-companys-collaborator-and-exclusive-licensee-in-china-simcere-pharmaceutical-has-submitted-its-new-drug-application-for-rademikibart-to-the-national-medical-products-administration-of-china-for-the-treatment-of-atopic-dermatitis
Connect Biopharma Holdings Announces Compa...
07/09/2025 13:02:56

Connect Biopharma Holdings Limited (NASDAQ:CNTB) ("Connect Biopharma", "Connect", or the "Company"), a ...

connect-biopharma-presents-clinical-data-supporting-rademikibart-anti-interleukin-4-receptor-alpha-antibody-at-eaaci-2025-annual-congress
Connect Biopharma Presents Clinical Data S...
06/13/2025 13:07:30

– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma –– Ra...

hc-wainwright--co-assumes-connect-biopharma-hldgs-at-buy-announces-price-target-of-7
HC Wainwright & Co. Assumes Connect Biopha...
06/12/2025 10:59:36

HC Wainwright & Co. analyst Brandon Folkes assumes Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy rating and announces...

connect-biopharma-files-for-mixed-shelf-offering-of-up-to-300m
Connect Biopharma Files For Mixed Shelf Of...
06/10/2025 20:38:51

-SEC Filing

connect-biopharma-announces-reduction-in-annualized-exacerbations-with-rademikibart-in-eosinophilic-driven-type-2-asthma-oral-presentations-and-improvement-in-lung-function-with-rademikibart-in-eosinophilic-driven-type-2-asthma--in-two-oral-presentations-at-european-academy-of-allergy-and-clinical-immunology-2025-annual-congress
Connect Biopharma Announces Reduction in A...
06/03/2025 13:06:21

connect-biopharma-presents-clinical-and-preclinical-data-supporting-rademikibart-at-ats-2025-international-conference
Connect Biopharma Presents Clinical And Pr...
05/20/2025 13:05:47

– Rademikibart significantly improved airway function, as measured by FEV1, within a day and significantly reduced acute exacer...

connect-biopharma-hldgs-q1-eps-019-down-from-016-yoy
Connect Biopharma Hldgs Q1 EPS $(0.19) Dow...
05/15/2025 13:05:44

Connect Biopharma Hldgs (NASDAQ:CNTB) reported quarterly losses of $(0.19) per share. This is a 18.75 percent decrease over los...

connect-biopharma-initiates-phase-2-seabreeze-stat-copd-study-following-written-agreement-on-final-study-protocol-from-fda-expects-to-report-topline-data-in-1h-2026
Connect Biopharma Initiates Phase 2 Seabre...
05/14/2025 13:05:28

– Expect to report topline data from the Seabreeze STAT COPD study in 1H 2026 –SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Conn...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION